FDA
-
-
-
-
-
-
-
Organovo On Track to Establish Human 3D Disease Model in Inflammatory Bowel Disease in 2022
-
-
-
-
-
-
-
Organovo (ONVO) Highlights Data on Creating Stem Cell-Based Bioprinted Kidney Organoids at ISSCR 2019 Meetings
-
-
-
-
-
-
-
Organovo Updates Key Clinical Development Goals; Company Reports Preliminary Fiscal Fourth-Quarter 2019 Results
-
-
-
-
-
-
-
Organovo Announces Release Date for Fiscal Third-Quarter 2019 Financial Results
-
-
-
-
-
-
-
Organovo (ONVO) to Present New Preclinical Data on 3D Bioprinted Human Liver Tissues for Treatment of Tyrosinemia I at AASLD
-
-
-
-
-
-
-
Organovo (ONVO) Reports In-Line Q4 EPS, Miss on Revenues
-
-
-
-
-
-
-
Pre-Open Movers 12/26: (DMPI) (APTO) (INSY) Higher; (SWKS) (AAPL) (CRUS) Lower (more...)
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

